NFKB1 and breast cancer: Moreover, activation of the NIK/RelB-p52 axis induces IDO expression in human MDSC-like cells cultured with breast cancer cells, suggesting that alternative NF-κB subunits may also promote immunosuppression in tumors through its role in MDSCs [49].